tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

RMDResMed

Health care · Medical Instruments · NYSE, OTC
Compare with peers → Embed
Insider trades since May 15, 2026

3 insiders sold $7.5M on the market, none bought

Form 4
Bought on the market
$0
0 trades
Sold on the market
$7.5M
8 trades by 3 insiders
Sold under a 10b5-1 planPlans →
100%
of the value sold, under a plan set up in advance
Traded the most
Michael J. Farrell
$5.3M Chairman and CEO

Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.

Who traded

Buys and sales by insider

Form 4, added up
InsiderTradesBoughtSoldShare of the totalOwned afterLatest
Michael J. Farrell
Chairman and CEO, Director
5 -$5.3M
71%
479,803 Oct 7, 2026
Peter C. Farrell
Director
2 -$2.0M
27%
51,803 Sep 2, 2026
Michael J. Rider
Global General Counsel
1 -$102K
1%
12,318 Oct 23, 2026
Every trade

Trade by trade, newest first

Each date links to its Form 4
DateInsiderRoleTypeSharesPriceValueOwned after
Oct 23, 2026 Michael J. RiderGlobal General Counsel Sale (10b5-1) -400 255.00 102K 12,318
Oct 7, 2026 Michael J. FarrellChairman and CEO, Director Sale (10b5-1) -4,991 226.33 1.1M 479,803
Sep 8, 2026 Michael J. FarrellChairman and CEO, Director Sale (10b5-1) -4,991 222.44 1.1M 466,256
Sep 2, 2026 Peter C. FarrellDirector Sale (10b5-1) -970 234.73 228K 51,803
Aug 7, 2026 Michael J. FarrellChairman and CEO, Director Sale (10b5-1) -4,991 205.69 1.0M 466,256
Aug 5, 2026 Peter C. FarrellDirector Sale (10b5-1) -8,000 225.00 1.8M 52,773
Jul 7, 2026 Michael J. FarrellChairman and CEO, Director Sale (10b5-1) -4,991 218.55 1.1M 466,223
Jun 8, 2026 Michael J. FarrellChairman and CEO, Director Sale (10b5-1) -4,991 193.96 968K 466,256
Next Insider selling plans →